Real-world effectiveness of olanzapine and risperidone in the treatment of schizophrenia in Brazil over a 16-year follow-up period; findings and implications-Reference-Cited by-同舟云学术

Real-world effectiveness of olanzapine and risperidone in the treatment of schizophrenia in Brazil over a 16-year follow-up period; findings and implications

Published:2020-12-31 Issue:2 Volume:14 Page:269-279
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Barbosa Wallace Breno¹²^ORCID,Gomes Rosângela Maria¹²^ORCID,Godman Brian³⁴⁵^ORCID,Acurcio Francisco de Assis¹²^ORCID,Guerra Júnior Augusto Afonso¹²^ORCID

Affiliation:

1. Department of Social Pharmacy, College of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil

2. , SUS Collaborating Centre‑Technology Assessment and Excellence in Health (CCATES/UFMG), Federal University of Minas Gerais, Belo Horizonte, Brazil

3. Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK

4. Division of Clinical Pharmacology, Karolinska, Karolinska Institute, Stockholm, Sweden

5. School of Pharmacy, Sefako Makgatho Health Sciences University, Garankuwa, South Africa

Funder

scholarship from Financial

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2021.1865799

Reference71 articles.

1. Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016

2. National Institute of Mental Health. Schizophrenia. 2020. [cited 2020 Mar]. Available from: https://www.nimh.nih.gov/health/topics/schizophrenia/index.shtml

3. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

4. Estimating the true global burden of mental illness

5. The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Effectiveness, Economic, and Humanistic Outcomes of Selected Oral Antipsychotics in Patients with Schizophrenia: A Systematic Review Evaluating Global Evidence;ClinicoEconomics and Outcomes Research;2024-09

2. The Effectiveness of Augmenting Modafinil to Risperidone or Olanzapine for Treating Negative Symptoms in Schizophrenic Patients: A Randomized Controlled Trail;Jundishapur Journal of Chronic Disease Care;2024-03-13

3. Variabilidade de preços de aquisição de medicamentos do grupo 1B do Componente Especializado da Assistência Farmacêutica;Ciência & Saúde Coletiva;2024

4. Olanzapine-induced nonalcoholic fatty liver disease: The effects of differential food pattern and the involvement of PGRMC1 signaling;Food and Chemical Toxicology;2023-06

5. Second-Generation Antipsychotics’ Effectiveness and Tolerability: A Review of Real-World Studies in Patients with Schizophrenia and Related Disorders;Journal of Clinical Medicine;2022-08-03